Cargando…
Myocardial protective effect of intracoronary administration of nicorandil and alprostadil via targeted perfusion microcatheter in patients undergoing elective percutaneous coronary intervention: A randomized controlled trial
BACKGROUND: The aim of the study was to evaluate the efficacy of nicorandil and alprostadil on myocardial protection in patients undergoing elective percutaneous coronary intervention (PCI). METHODS: In this prospective, single-blinded, randomized controlled study, 90 consecutive patients scheduled...
Autores principales: | Zhang, Weifeng, Dai, Jinjie, Zheng, Xiaowen, Xu, Ke, Yang, Xiaoxiao, Shen, Lan, Wang, Xiaolei, Hao, Ziyong, Qiu, Xingbiao, Jiang, Lisheng, Shi, Hongyu, Shen, Linghong, He, Ben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052047/ https://www.ncbi.nlm.nih.gov/pubmed/33847683 http://dx.doi.org/10.1097/MD.0000000000025551 |
Ejemplares similares
-
Alprostadil vs. isosorbide dinitrate in ameliorating angina episodes in patients with coronary slow flow phenomenon: A randomized controlled trial
por: Zhang, Weifeng, et al.
Publicado: (2022) -
The effect of alprostadil on preventing contrast-induced nephropathy for percutaneous coronary intervention in diabetic patients: A systematic review and meta-analysis
por: Ye, Ziliang, et al.
Publicado: (2016) -
Impact of administration of nicorandil prior to percutaneous coronary intervention in treatment of acute myocardial infarction: A protocol for systematic review and meta-analysis
por: Li, Weijun, et al.
Publicado: (2021) -
The effect of nicorandil in patients with cardiac syndrome X: A meta-analysis of randomized controlled trials
por: Jia, Qiulei, et al.
Publicado: (2020) -
The effectiveness and safety of nicorandil in the treatment of patients with microvascular angina: A protocol for systematic review and meta-analysis
por: Zhang, Ye, et al.
Publicado: (2021)